Log in to save to my catalogue

Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia

Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2cd886b587c94bdaa2bd04fdff849913

Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Rearrangments in Histone-lysine-N-methyltransferase 2A (KMT2Ar) are associated with pediatric, adult and therapy-induced acute leukemias. Infants with KMT2Ar acute lymphoblastic leukemia (ALL) have a poor prognosis with an event-free-survival of 38%. Herein we evaluate 1116 FDA approved compounds in primary KMT2Ar infant ALL specimens and identify...

Alternative Titles

Full title

Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2cd886b587c94bdaa2bd04fdff849913

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2cd886b587c94bdaa2bd04fdff849913

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-36370-x

How to access this item